| Literature DB >> 29204071 |
Sonia Iurian1, Elena Dinte1, Cristina Iuga2, Cătălina Bogdan3, Iuliana Spiridon4, Lucian Barbu-Tudoran5, Andreea Bodoki6, Ioan Tomuţă1, Sorin E Leucuţa1.
Abstract
The aim of the present study was to evaluate the funtion of fenugreek seed mucilage (FSM) as potential matrix forming agent for orodispersible pharmaceutical lyophilisates. The FSM was isolated and characterized. FSM colloidal dispersions were prepared and the rheological evaluation was performed. Oral lyophilisates (OLs) with different FSM concentrations, containing meloxicam as model drug were prepared by freeze drying method. The OLs were characterized and compared to gelatin containing tablets, prepared under the same conditions. The FSM dispersions revealed shear thinning flow type. Based on colloidal dispersions' rheological properties, five FSM concentrations were taken forward to the lyophilization step. Completely dry and elegant tablets were obtained. Texture analysis indicated highly porous structures, confirmed by SEM analysis, which explain the fast disintegration properties. All the prepared tablets disintegrated in less than 47 s. The disintegration process was prolonged by the increase in FSM content, due to the high viscosity the polymer creates in aqueous media. FSM tablets presented longer disintegration times, as compared to gelatin tablets, but also higher crushing strength. Considering the fast disintegration and the high crushing strength, FSM is a good candidate as matrix forming agent for fast disintegrating dosage forms or other freeze-dried preparations.Entities:
Keywords: Galactomannan; Lyophilization; Matrix forming agent; Meloxicam; Oral lyophilisates
Year: 2017 PMID: 29204071 PMCID: PMC5688226 DOI: 10.1016/j.jsps.2017.09.006
Source DB: PubMed Journal: Saudi Pharm J ISSN: 1319-0164 Impact factor: 4.330
The composition and Tg’ of the suspensions prepared for freeze drying.
| Components | Formulations | ||||||
|---|---|---|---|---|---|---|---|
| A | B | C | D | E | F | G | |
| Meloxicam (g) | 0.45 | 0.45 | 0.45 | 0.45 | 0.45 | 0.45 | 0.45 |
| Mannitol (g) | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 | 1.50 |
| 0.50% FSM dispersion | q.s. | – | – | – | – | ||
| 0.75% FSM dispersion | – | q.s. | – | – | – | ||
| 1% FSM dispersion | – | – | q.s | – | – | ||
| 1.25% FSM dispersion | – | – | – | q.s. | – | ||
| 1.50% FSM dispersion | – | – | – | – | q.s. | ||
| 1% Gelatin dispersion | – | – | – | – | – | q.s. | – |
| 5% Gelatin dispersion | – | – | – | – | – | – | q.s. |
| Final volume (ml) | 30 | 30 | 30 | 30 | 30 | 30 | 30 |
| −25.66 | −26.62 | −29.29 | −29.90 | −29.55 | −20.77 | −20.25 | |
q.s. = quantum satis – completed as necessary until the final volume.
Freeze drying and annealing processes parameters.
| Step | Thermal treatment | Primary drying | ||||
|---|---|---|---|---|---|---|
| Temperature (°C) | Time (min) | Ramp/Hold (R/H) | Temperature (°C) | Time (min) | Vacuum (mTorr) | |
| 1 | −55 | 120 | H | −20 | 1200 | 300 |
| 2 | −12 | 180 | H | Secondary drying | ||
| 3 | −55 | 120 | H | +5 | 600 | 50 |
Polymer size, polydispersion index and Zeta potential.
| FSM content (%) | Zeta Potential* (mV) | Conductivity* (mS/cm) | z-Average diameter* (nm) |
|---|---|---|---|
| 0.01 | −20.4 ± 3.20 | 0.0248 ± 0.0006 | 761.13 ± 64.89 |
| 0.02 | −20.26 ± 0.97 | 0.0262 ± 0.0013 | 860.33 ± 59.25 |
| 0.05 | −16.1 ± 0.62 | 0.0481 ± 0.0013 | 1139.33 ± 64.60 |
| 0.1 | −14.8 ± 1.74 | 0.0922 ± 0.0001 | 1767.66 ± 36.14 |
| 0.2 | −16.93 ± 0.58 | 0.1703 ± 0.0005 | 2801.33 ± 96.47 |
Values represent means ± standard deviation from triplicate.
Fig. 1The flowing curves of fenugreek seed mucilage (FSM) colloidal dispersions containing increasing FSM concentrations, as it follows: (a) 0.25% FSM, (b) 0.5% FSM, (c) 0.75% FSM, (d) 1% FSM, (e) 1.25% FSM, (f) 1.5% FSM, (g) 2% FSM. Values represent means of three determinations; for clarity, the error bars were not shown.
Power-law model parameters and viscosity values for studied FSM colloidal dispersions.
| FSM colloidal dispersion concentration (%) | Rheological parameters | |||
|---|---|---|---|---|
| K | n | r2 | Viscosity at 10 rpm | |
| 0.25 | 0.4181 ± 0.0155 | 0.9487 ± 0.0066 | 0.9761 | 32 ± 1 |
| 0.5 | 0.4212 ± 0.0442 | 0.9967 ± 0.0225 | 0.9631 | 42 ± 2.6457 |
| 0.75 | 1.1826 ± 0.1239 | 0.8337 ± 0.0181 | 0.9773 | 55 ± 1.7320 |
| 1 | 28.1190 ± 0.0656 | 0.5947 ± 0.0013 | 0.9942 | 1153.33 ± 5.7735 |
| 1.25 | 44.8339 ± 0.3133 | 0.5646 ± 0.0012 | 0.9936 | 2320 ± 0.00 |
| 1.5 | 62.1794 ± 0.5970 | 0.5137 ± 0.0042 | 0.9937 | 4096.66 ± 55.0757 |
| 2 | 134.039 ± 0.1083 | 0.3845 ± 0.0036 | 0.996 | 12200 ± 200 |
Values represent means ± standard deviation from triplicate.
Fig. 2DSC thermogram of meloxicam suspension containing FSM 1%, showing the effect of the annealing step.
Physical characterization of oral lyophilisates (homogeneity, weight, diameter and thickness) and disintegration properties (disintegration time, wetting time, water absorption ratio).
| Matrix forming agent | Content (%) | Formulation | Homogeneity | Weight | Diameter and thickness (cm) | Disintegration time | Wetting time | Water absorption ratio |
|---|---|---|---|---|---|---|---|---|
| FSM | 0.5 | A | – | 30.25 ± 1.11 | 1.17 and 4.64 | 4.00 ± 0.89a | 1.00 ± 0.00a | 158.32 ± 3.24a |
| 0.75 | B | – | 41.6 ± 1.63 | 1.17 and 4.64 | 5.33 ± 0.41b | 1.00 ± 0.00a | 249.59 ± 18.63b | |
| 1 | C | + | 41.8 ± 1.79 | 1.17 and 4.66 | 10.67 ± 4.03c | 89.33 ± 4.81b | 326.46 ± 41.52c | |
| 1.25 | D | + | 44.1 ± 1.65 | 1.17 and 4.66 | 14.67 ± 3.72c | 151.00 ± 20.95c | 341.47 ± 32.91 cd | |
| 1.5 | E | + | 38.6 ± 1.84 | 1.17 and 4.67 | 46.50 ± 6.29d | 201.67 ± 26.50c | 369.78 ± 24.18d | |
| Gelatin | 1 | F | – | 37.9 ± 0.91 | 1.17 and 4.58 | 2.50 ± 0.24e | 1.17 ± 0.28d | 25.55 ± 3.02e |
| 5 | G | – | 54.2 ± 1.39 | 1.17 and 4.62 | 3.50 ± 0.24f | 2.00 ± 0.00e | 9.24 ± 1.78f | |
Values in a column followed by different letters in superscripts show significant differences within the same column (p < 0.05).
+ = meloxicam has not settled at the bottom of the tablet, the aspect was homogenous; - = insoluble meloxicam has settled at the bottom of the tablet, as a yellow layer.
Values of the weight of tablets represent the mean ± standard deviation (n = 20).
Values represent the mean ± standard deviation (n = 3).
Fig. 3Hardness profiles of the oral lyophilisates. Values represent means of three determinations; for clarity, the error bars were not shown.
Fig. 4Dissolution profiles of OL formulations containing different concentrations of FSM or Gelatin as matrix forming agents. Values represent means of three determinations.
Fig. 5(a) DSC curves showing the thermal behavior of meloxicam, FSM, mannitol and Formulation C containing 1% FSM, (b) FTIR spectra of meloxicam, FSM, mannitol and Formulation C containing 1% FSM.
Fig. 6SEM micrographs of oral lyophilisates: (A) tablet C – 1% FSM; (B) tablet F – 1% Gelatin; (C) tablet G – 5% Gelatin at 300x magnification.